Search

Scott Dodds

Examiner (ID: 5800, Phone: (571)270-7653 , Office: P/1746 )

Most Active Art Unit
1746
Art Unit(s)
1791, 1746
Total Applications
996
Issued Applications
635
Pending Applications
97
Abandoned Applications
283

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6543908 [patent_doc_number] => 20100204673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'OBESITY CONTROLLING METHOD' [patent_app_type] => utility [patent_app_number] => 12/566886 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204673.pdf [firstpage_image] =>[orig_patent_app_number] => 12566886 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/566886
OBESITY CONTROLLING METHOD Sep 24, 2009 Abandoned
Array ( [id] => 6602766 [patent_doc_number] => 20100062976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Synthesis of Cyclosporin Analogs' [patent_app_type] => utility [patent_app_number] => 12/555787 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26969 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062976.pdf [firstpage_image] =>[orig_patent_app_number] => 12555787 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/555787
Synthesis of Cyclosporin Analogs Sep 7, 2009 Abandoned
Array ( [id] => 5398297 [patent_doc_number] => 20090318360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Use of the neurotoxic component of a botulinum toxin for treating arthritis' [patent_app_type] => utility [patent_app_number] => 12/550331 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318360.pdf [firstpage_image] =>[orig_patent_app_number] => 12550331 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/550331
Use of the neurotoxic component of a botulinum toxin for treating arthritis Aug 27, 2009 Issued
Array ( [id] => 6412894 [patent_doc_number] => 20100166782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/508543 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 68057 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166782.pdf [firstpage_image] =>[orig_patent_app_number] => 12508543 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/508543
CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION Jul 22, 2009 Abandoned
Array ( [id] => 5464507 [patent_doc_number] => 20090324707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES' [patent_app_type] => utility [patent_app_number] => 12/499500 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7717 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324707.pdf [firstpage_image] =>[orig_patent_app_number] => 12499500 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/499500
METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES Jul 7, 2009 Abandoned
Array ( [id] => 5464507 [patent_doc_number] => 20090324707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES' [patent_app_type] => utility [patent_app_number] => 12/499500 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7717 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324707.pdf [firstpage_image] =>[orig_patent_app_number] => 12499500 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/499500
METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES Jul 7, 2009 Abandoned
Array ( [id] => 6275317 [patent_doc_number] => 20100256074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Processes for preparing high purity aza cyclohexapeptides' [patent_app_type] => utility [patent_app_number] => 12/459180 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6688 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256074.pdf [firstpage_image] =>[orig_patent_app_number] => 12459180 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/459180
Processes for preparing high purity aza cyclohexapeptides Jun 24, 2009 Abandoned
Array ( [id] => 4496128 [patent_doc_number] => 07947654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 12/487116 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9485 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947654.pdf [firstpage_image] =>[orig_patent_app_number] => 12487116 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/487116
Pharmaceutical formulations Jun 17, 2009 Issued
Array ( [id] => 6317196 [patent_doc_number] => 20100112619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'LIGAND-CONTAINING MICELLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/469597 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 47902 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112619.pdf [firstpage_image] =>[orig_patent_app_number] => 12469597 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/469597
LIGAND-CONTAINING MICELLES AND USES THEREOF May 19, 2009 Abandoned
Array ( [id] => 5398604 [patent_doc_number] => 20090318667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Peptoid compositions and methods of using the same' [patent_app_type] => utility [patent_app_number] => 12/454381 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8736 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 86 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318667.pdf [firstpage_image] =>[orig_patent_app_number] => 12454381 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/454381
Peptoid compositions and methods of using the same May 14, 2009 Abandoned
Array ( [id] => 5398273 [patent_doc_number] => 20090318336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Deuterated Cyclosporine Analogs and Methods of Making the Same' [patent_app_type] => utility [patent_app_number] => 12/427692 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10757 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318336.pdf [firstpage_image] =>[orig_patent_app_number] => 12427692 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/427692
Deuterated Cyclosporine Analogs and Methods of Making the Same Apr 20, 2009 Abandoned
Array ( [id] => 5403543 [patent_doc_number] => 20090238857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'USE OF HYDROPHOBIC CROSSLINKING AGENTS TO PREPARE CROSSLINKED BIOMATERIAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/388134 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7952 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238857.pdf [firstpage_image] =>[orig_patent_app_number] => 12388134 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/388134
USE OF HYDROPHOBIC CROSSLINKING AGENTS TO PREPARE CROSSLINKED BIOMATERIAL COMPOSITIONS Feb 17, 2009 Abandoned
Array ( [id] => 5545985 [patent_doc_number] => 20090155862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols' [patent_app_type] => utility [patent_app_number] => 12/379297 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4527 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155862.pdf [firstpage_image] =>[orig_patent_app_number] => 12379297 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/379297
Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols Feb 17, 2009 Abandoned
Array ( [id] => 5472967 [patent_doc_number] => 20090246133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'METHODS AND COMPOSITIONS RELATED TO INTERNALIZING RGD PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/355672 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23038 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246133.pdf [firstpage_image] =>[orig_patent_app_number] => 12355672 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/355672
Methods and compositions related to internalizing RGD peptides Jan 15, 2009 Issued
Array ( [id] => 8421784 [patent_doc_number] => 08278272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'GLP-1, exendin-4, peptide analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/317042 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 38 [patent_no_of_words] => 26288 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12317042 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/317042
GLP-1, exendin-4, peptide analogs and uses thereof Dec 17, 2008 Issued
Array ( [id] => 5546628 [patent_doc_number] => 20090156505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'SELF-ASSEMBLY AND MINERALIZATION OF PEPTIDE-AMPHIPHILE NANOFIBERS' [patent_app_type] => utility [patent_app_number] => 12/330468 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7169 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156505.pdf [firstpage_image] =>[orig_patent_app_number] => 12330468 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/330468
Self-assembly and mineralization of peptide-amphiphile nanofibers Dec 7, 2008 Issued
Array ( [id] => 5380450 [patent_doc_number] => 20090192289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'OMI PDZ MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/270517 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26619 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192289.pdf [firstpage_image] =>[orig_patent_app_number] => 12270517 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/270517
OMI PDZ MODULATORS Nov 12, 2008 Abandoned
Array ( [id] => 5564642 [patent_doc_number] => 20090137495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Organic Compounds and Their Uses' [patent_app_type] => utility [patent_app_number] => 12/249186 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29274 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137495.pdf [firstpage_image] =>[orig_patent_app_number] => 12249186 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/249186
Organic compounds and their uses Oct 9, 2008 Issued
Array ( [id] => 5539985 [patent_doc_number] => 20090221790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS' [patent_app_type] => utility [patent_app_number] => 12/247119 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10265 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221790.pdf [firstpage_image] =>[orig_patent_app_number] => 12247119 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/247119
METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS Oct 6, 2008 Abandoned
Array ( [id] => 4442281 [patent_doc_number] => 07928065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Methods of treatment using exendin peptides or GLP-1 peptides' [patent_app_type] => utility [patent_app_number] => 12/247141 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23813 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928065.pdf [firstpage_image] =>[orig_patent_app_number] => 12247141 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/247141
Methods of treatment using exendin peptides or GLP-1 peptides Oct 6, 2008 Issued
Menu